Royalty Pharma Plc Stock Price History

RPRX Stock  USD 32.36  0.10  0.31%   
Below is the normalized historical share price chart for Royalty Pharma Plc extending back to June 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Royalty Pharma stands at 32.36, as last reported on the 17th of February 2025, with the highest price reaching 32.89 and the lowest price hitting 32.28 during the day.
IPO Date
25th of March 1993
200 Day MA
27.6396
50 Day MA
28.3668
Beta
0.489
 
Covid
If you're considering investing in Royalty Stock, it is important to understand the factors that can impact its price. Royalty Pharma appears to be very steady, given 3 months investment horizon. Royalty Pharma Plc maintains Sharpe Ratio (i.e., Efficiency) of 0.2, which implies the firm had a 0.2 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Royalty Pharma Plc, which you can use to evaluate the volatility of the company. Please evaluate Royalty Pharma's Semi Deviation of 0.7097, coefficient of variation of 531.02, and Risk Adjusted Performance of 0.1396 to confirm if our risk estimates are consistent with your expectations.
  
At this time, Royalty Pharma's Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 2.4 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 418.8 M in 2025. . Price To Free Cash Flows Ratio is likely to rise to 4.33 in 2025, whereas Price To Sales Ratio is likely to drop 4.79 in 2025. Royalty Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1995

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsRPRX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.91
  actual daily
17
83% of assets are more volatile

Expected Return

 0.38
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.2
  actual daily
15
85% of assets perform better
Based on monthly moving average Royalty Pharma is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Royalty Pharma by adding it to a well-diversified portfolio.
Price Book
2.0186
Enterprise Value Ebitda
12.7633
Price Sales
8.241
Shares Float
372.9 M
Dividend Share
0.84

Royalty Pharma Stock Price History Chart

There are several ways to analyze Royalty Stock price data. The simplest method is using a basic Royalty candlestick price chart, which shows Royalty Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 13, 202532.46
Lowest PriceDecember 19, 202424.28

Royalty Pharma February 17, 2025 Stock Price Synopsis

Various analyses of Royalty Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Royalty Stock. It can be used to describe the percentage change in the price of Royalty Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Royalty Stock.
Royalty Pharma Price Daily Balance Of Power(0.16)
Royalty Pharma Price Rate Of Daily Change 1.00 
Royalty Pharma Price Action Indicator(0.28)

Royalty Pharma February 17, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Royalty Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Royalty Pharma intraday prices and daily technical indicators to check the level of noise trading in Royalty Stock and then apply it to test your longer-term investment strategies against Royalty.

Royalty Stock Price History Data

The price series of Royalty Pharma for the period between Tue, Nov 19, 2024 and Mon, Feb 17, 2025 has a statistical range of 8.18 with a coefficient of variation of 9.98. The price distribution for the period has arithmetic mean of 27.82. The median price for the last 90 days is 26.34. The company completed stock split (1:4) on 15th of October 2010. Royalty Pharma Plc had dividends distributed to its stock-holders on 2025-02-21.
OpenHighLowCloseVolume
02/17/2025
 32.46  32.89  32.28  32.36 
02/17/2025
 32.46  32.89  32.28  32.36 
02/14/2025 32.46  32.89  32.28  32.36  4,822,374 
02/13/2025 32.39  32.63  32.13  32.46  3,979,839 
02/12/2025 32.27  32.56  31.73  32.34  3,662,213 
02/11/2025 31.60  32.72  31.30  32.25  7,665,139 
02/10/2025 31.73  31.79  31.35  31.72  3,343,504 
02/07/2025 31.48  31.75  31.36  31.73  3,393,397 
02/06/2025 31.62  31.63  31.23  31.40  3,373,697 
02/05/2025 31.34  31.64  31.18  31.45  3,155,070 
02/04/2025 31.03  31.60  31.03  31.26  3,623,559 
02/03/2025 31.07  31.66  31.07  31.33  3,080,007 
01/31/2025 31.64  31.68  31.22  31.58  4,071,952 
01/30/2025 31.93  32.06  31.49  31.59  3,890,145 
01/29/2025 32.00  32.21  31.61  31.95  5,471,126 
01/28/2025 31.82  32.12  31.60  31.94  6,875,643 
01/27/2025 31.11  31.76  30.95  31.72  3,704,130 
01/24/2025 30.61  31.10  30.61  31.06  5,780,103 
01/23/2025 30.13  30.65  30.04  30.62  5,347,998 
01/22/2025 30.09  30.21  29.73  30.08  3,541,447 
01/21/2025 30.79  30.80  30.26  30.30  2,794,612 
01/17/2025 30.72  31.08  30.52  30.75  2,887,148 
01/16/2025 30.64  31.09  30.11  30.95  4,829,577 
01/15/2025 30.23  30.82  30.01  30.74  4,510,597 
01/14/2025 29.90  30.20  29.67  30.03  5,888,176 
01/13/2025 29.83  30.78  29.77  29.99  7,816,924 
01/10/2025 27.55  29.89  27.47  29.49  8,066,463 
01/08/2025 25.98  26.37  25.77  26.20  2,225,778 
01/07/2025 25.63  26.06  25.55  26.04  2,727,346 
01/06/2025 25.73  26.10  25.40  25.75  2,232,329 
01/03/2025 25.81  25.96  25.72  25.84  2,082,916 
01/02/2025 25.55  25.89  25.55  25.79  1,521,459 
12/31/2024 25.30  25.59  25.28  25.51  2,179,396 
12/30/2024 25.41  25.50  25.18  25.32  1,914,509 
12/27/2024 25.27  25.68  25.27  25.54  2,036,094 
12/26/2024 25.19  25.46  25.16  25.40  1,740,149 
12/24/2024 25.23  25.35  25.02  25.23  1,350,225 
12/23/2024 24.72  25.26  24.46  25.25  5,439,334 
12/20/2024 24.34  25.00  24.32  24.92  7,574,662 
12/19/2024 24.24  24.48  24.05  24.28  4,359,724 
12/18/2024 25.09  25.27  24.46  24.47  3,737,456 
12/17/2024 25.06  25.27  24.80  25.12  3,046,241 
12/16/2024 24.75  25.28  24.70  25.00  4,385,627 
12/13/2024 25.17  25.17  24.73  24.84  2,540,924 
12/12/2024 25.11  25.42  25.10  25.21  2,891,122 
12/11/2024 25.43  25.50  25.02  25.20  2,851,459 
12/10/2024 26.05  26.05  25.46  25.59  3,130,284 
12/09/2024 25.81  26.22  25.62  26.01  2,588,855 
12/06/2024 26.42  26.59  25.87  25.91  4,327,547 
12/05/2024 26.10  26.54  26.10  26.39  2,390,475 
12/04/2024 26.24  26.36  25.94  26.10  2,973,111 
12/03/2024 26.32  26.47  26.15  26.34  3,191,202 
12/02/2024 26.52  26.60  26.29  26.43  2,113,638 
11/29/2024 26.60  26.66  26.46  26.66  1,411,354 
11/27/2024 26.35  26.65  26.23  26.60  1,811,787 
11/26/2024 26.59  26.62  26.02  26.29  1,991,661 
11/25/2024 26.46  26.83  26.41  26.47  6,834,103 
11/22/2024 26.38  26.63  26.33  26.43  2,461,722 
11/21/2024 26.26  26.67  26.23  26.40  4,329,564 
11/20/2024 26.09  26.29  25.80  26.22  2,006,893 
11/19/2024 25.63  26.03  25.47  26.01  7,299,478 

About Royalty Pharma Stock history

Royalty Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Royalty is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Royalty Pharma Plc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Royalty Pharma stock prices may prove useful in developing a viable investing in Royalty Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding592.7 M418.8 M
Net Income Applicable To Common Shares49.3 M46.8 M

Royalty Pharma Quarterly Net Working Capital

548.52 Million

Royalty Pharma Stock Technical Analysis

Royalty Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Royalty Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Royalty Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run ETFs Now

   

ETFs

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module

Royalty Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Royalty Pharma's price direction in advance. Along with the technical and fundamental analysis of Royalty Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Royalty to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Royalty Stock Analysis

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.